Previous studies have demonstrated that dysregulated metabolism of DNA epigenetic modifications leads to the regulation of neuronal apoptosis-related gene expression, including BAX and Bcl-2, in the pathogenesis of neurodegenerative disease (44, 45). This evidence concerns the gene BAX and neurodegenerative disease.